China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 95.0% in February

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 4,700 shares, a decrease of 95.0% from the January 31st total of 94,100 shares. Based on an average daily volume of 172,200 shares, the short-interest ratio is presently 0.0 days.

China SXT Pharmaceuticals Trading Down 2.0 %

NASDAQ:SXTC opened at $4.50 on Friday. The stock has a fifty day simple moving average of $3.47 and a 200 day simple moving average of $4.31. China SXT Pharmaceuticals has a 1-year low of $2.40 and a 1-year high of $26.96.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Further Reading

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.